BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,288,760 | +2.2% | 747,000 | +1.7% | 0.02% | +5.9% |
| Q2 2023 | $5,172,992 | -19.7% | 734,800 | -4.8% | 0.02% | -26.1% |
| Q1 2023 | $6,439,314 | -57.0% | 772,100 | -40.9% | 0.02% | -34.3% |
| Q4 2022 | $14,988,288 | -13.0% | 1,305,600 | -4.5% | 0.04% | +2.9% |
| Q3 2022 | $17,224,000 | +14.0% | 1,367,000 | -4.3% | 0.03% | +41.7% |
| Q2 2022 | $15,109,000 | -42.9% | 1,428,100 | -12.2% | 0.02% | -7.7% |
| Q1 2022 | $26,440,000 | +9.5% | 1,626,100 | -6.7% | 0.03% | +36.8% |
| Q4 2021 | $24,146,000 | +31.3% | 1,743,400 | +36.3% | 0.02% | -5.0% |
| Q3 2021 | $18,384,000 | -6.3% | 1,279,300 | +3.1% | 0.02% | -16.7% |
| Q2 2021 | $19,623,000 | +117.7% | 1,241,200 | +40.0% | 0.02% | +84.6% |
| Q1 2021 | $9,014,000 | +299.0% | 886,300 | +192.3% | 0.01% | +225.0% |
| Q4 2020 | $2,259,000 | +102.4% | 303,200 | -6.7% | 0.00% | 0.0% |
| Q3 2020 | $1,116,000 | -28.2% | 324,900 | -0.4% | 0.00% | -42.9% |
| Q2 2020 | $1,555,000 | +200.2% | 326,300 | +26.0% | 0.01% | +75.0% |
| Q1 2020 | $518,000 | +215.9% | 259,000 | +444.1% | 0.00% | +300.0% |
| Q4 2019 | $164,000 | +56.2% | 47,600 | +30.4% | 0.00% | 0.0% |
| Q3 2019 | $105,000 | -82.3% | 36,500 | -76.6% | 0.00% | -80.0% |
| Q2 2019 | $592,000 | +529.8% | 156,200 | +1246.6% | 0.01% | +400.0% |
| Q1 2019 | $94,000 | -59.0% | 11,600 | -59.2% | 0.00% | -50.0% |
| Q4 2018 | $229,000 | +41.4% | 28,400 | +34.0% | 0.00% | +100.0% |
| Q3 2018 | $162,000 | +575.0% | 21,200 | +404.8% | 0.00% | – |
| Q2 2018 | $24,000 | -70.4% | 4,200 | -75.3% | 0.00% | -100.0% |
| Q1 2018 | $81,000 | +37.3% | 17,000 | +40.5% | 0.00% | – |
| Q4 2017 | $59,000 | -47.3% | 12,100 | -43.5% | 0.00% | -100.0% |
| Q3 2017 | $112,000 | -91.7% | 21,400 | -91.2% | 0.00% | -92.9% |
| Q2 2017 | $1,356,000 | -47.0% | 243,900 | -20.0% | 0.01% | -53.3% |
| Q1 2017 | $2,559,000 | +44.1% | 304,700 | +8.6% | 0.03% | +76.5% |
| Q4 2016 | $1,776,000 | +514.5% | 280,500 | +327.6% | 0.02% | +466.7% |
| Q3 2016 | $289,000 | +1964.3% | 65,600 | +1212.0% | 0.00% | – |
| Q2 2016 | $14,000 | -50.0% | 5,000 | -50.0% | 0.00% | – |
| Q1 2016 | $28,000 | -95.4% | 10,000 | -83.1% | 0.00% | -100.0% |
| Q4 2015 | $612,000 | -7.7% | 59,300 | +1.9% | 0.01% | -22.2% |
| Q3 2015 | $663,000 | -51.1% | 58,200 | -36.0% | 0.01% | -52.6% |
| Q2 2015 | $1,357,000 | +876.3% | 90,900 | +490.3% | 0.02% | +850.0% |
| Q1 2015 | $139,000 | -87.6% | 15,400 | -83.3% | 0.00% | -88.2% |
| Q4 2014 | $1,120,000 | +364.7% | 92,100 | +274.4% | 0.02% | +325.0% |
| Q3 2014 | $241,000 | -70.6% | 24,600 | -61.8% | 0.00% | -69.2% |
| Q2 2014 | $821,000 | +1.9% | 64,400 | -15.5% | 0.01% | -7.1% |
| Q1 2014 | $806,000 | +492.6% | 76,200 | +325.7% | 0.01% | +600.0% |
| Q4 2013 | $136,000 | -88.6% | 17,900 | -89.0% | 0.00% | -91.3% |
| Q3 2013 | $1,190,000 | +1703.0% | 163,400 | +282.7% | 0.02% | +1050.0% |
| Q2 2013 | $66,000 | – | 42,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,241,200 | $19,623,000 | 0.02% |
| SIMPLEX TRADING, LLC | 241,800 | $3,822,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |